期刊文献+

Strategy for treatment of nonerosive reflux disease in Asia 被引量:10

Strategy for treatment of nonerosive reflux disease in Asia
下载PDF
导出
摘要 The paper is to review the clinical and pathophysiologic differences between of nonerosive reflux disease (NERD) and reflux esophagitis (RE), and to propose a treatment strategy for NERD, especially for patients in Asia. A Medline search was performed regarding the clinical and pathophysiologic differences between NERD and RE, and treatment of NERD and RE. The characteristics of NERD patients in Asia are as follows: (1) high proportion of female patients, (2) low frequency of hiatal hernia, (3) high frequency of H pylori infection, (4) severe glandular atrophy of the gastric mucosa, and (5) frequent resistance to proton pump inhibitor (PPI) therapy. In Asian NERD patients, exposure of the esophagus to acid is not increased, and esophageal motility is normal. These characteristics are similar to those of patients in Western countries. Our recommended first-choice treatment is administration of PPI in combination with a prokinetic agent. However, at present, because there is limited evidence regarding effective treatments for NERD, it is best to try several different treatment strategies to find the best treatment for each patient. The paper is to review the clinical and pathophysiologic differences between of nonerosive reflux disease (NERD) and reflux esophagitis (RE), and to propose a treatment strategy for NERD, especially for patients in Asia. A Medline search was performed regarding the clinical and pathophysiologic differences between NERD and RE, and treatment of NERD and RE. The characteristics of NERD patients in Asia are as follows: (1) high proportion of female patients, (2) low frequency of hiatal hernia, (3) high frequency of H pylori infection, (4) severe glandular atrophy of the gastric mucosa, and (5) frequent resistance to proton pump inhibitor (PPI) therapy. In Asian NERD patients, exposure of the esophagus to acid is not increased, and esophageal motility is normal. These characteristics are similar to those of patients in Western countries. Our recommended first-choice treatment is administration of PPI in combination with a prokinetic agent. However, at present, because there is limited evidence regarding effective treatments for NERD, it is best to try several different treatment strategies to find the best treatment for each patient.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2008年第20期3123-3128,共6页 世界胃肠病学杂志(英文版)
关键词 Nonerosive reflux disease ASIA TREATMENT 亚洲 食管反流病 治疗方法 临床分析
  • 相关文献

参考文献57

  • 1[1]Vakil N,van Zanten SV,Kahrilas P,Dent J,Jones R.The Montreal definition and classification of gastroesophageal reflux disease:a global evidence-based consensus.Am J Gastroenterol 2006;101:1900-1920;quiz 1943
  • 2[2]Moayyedi P,Talley NJ.Gastro-oesophageal reflux disease.Lancet 2006;367:2086-2100
  • 3[3]Faas R.Erosive esophagitis and nonerosive reflux disease (NERD):comparison of epidemiologic,physiologic,and therapeutic characteristics.J Clin Gastroenterol 2007;41:131-137
  • 4[4]Wong BC,Kinoshita Y.Systematic review on epidemiology of gastroesophageal reflux disease in Asia.Clin Gastroenterol Hepatol 2006;4:398-407
  • 5[5]Lundell LR,Dent J,Bennett JR,Blum AL,Armstrong D,Galmiche JP,Johnson F,Hongo M,Richter JE,Spechler SJ,Tytgat GN,Wallin L.Endoscopic assessment of oesophagitis:clinical and functional correlates and further validation of the Los Angeles classification.Gut 1999;45:172-180
  • 6[6]Manabe IN,Yoshihara M,Sasaki A,Tanaka S,Haruma K,Chayama K.Clinical characteristics and natural history of patients with low-grade reflux esophagitis.J Gastroenterol Hepatol 2002;17:949-954
  • 7[7]Kuster E,Ros E,Toledo-Pimentel V,Pujol A,Bordas JM,Grande L,Pera C.Predictive factors of the long term outcome in gastro-oesophageal reflux disease:six year follow up of 107 patients.Gut 1994;35:8-14
  • 8[8]Sontag SJ,Sonnenberg A,Schnell TG,Leya J,Metz A.The long-term natural history of gastroesophageal reflux disease,J Clin Gastroenterol 2006;40:398-404
  • 9[9]Fullard M,Kang JY,Neild P,Poullis A,Maxwell JD.Systematic review:does gastro-oesophageal reflux disease progress? Aliment Pharmacol Ther 2006;24:33-45
  • 10[10]Fujiwara Y,Higuchi K,Shiba M,Yamamori K,Watanabe Y,Sasaki E,Tominaga K,Watanabe T,Oshitani N,Arakawa T.Differences in clinical characteristics between patients with endoscopy-negative reflux disease and erosive esophagitis in Japan.Am J Gastroenterol 2005;100:754-758

同被引文献84

引证文献10

二级引证文献184

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部